Use of Lactic acid Bacteria as Antigen Delivery Vehicle Kim, Tae-Woon Lab. of Food Biochemistry.

Slides:



Advertisements
Similar presentations
(mechanisms of defense against viral, parasitic and fungal infections)
Advertisements

 Chapter 43: Immune System. Learning Targets 1. I can explain innate immunity by:  Describing barrier defenses  Describing internal defenses 2. I can.
Potential prophylactic BCG Prime-booster Gaëlle Noël Kidist Bobosha Subgroup A2 March 16 th, 2011.
Construction of Phix174 gene E mediated lysis system for generation of Salmonella Enteritidis ghost, and its evaluation as a vaccine candidate for the.
Designing and Optimizing an Adenovirus Encoded VLP Vaccine against HIV Anne-Marie Andersson PhD Student, University of Copenhagen.
Immunity to microbes (mechanisms of defense against
Defenses Against Infection 1. Innate responses (humoral and cellular) 2. Immunity to intracellular pathogens NK cells, control of Th1/Th2 responses 3.
The Role of Interleukin-10 in Burkholderia Infection of Human Mononuclear Cells Amy K. Dickey MD MSc, Johanna D. Robertson BS, T. Eoin West MD MPH Department.
Immune Response against Infectious Diseases
Goals of PATHOGENOMICS related research Chief Scientist Office Ministry of Health Israel.
Food Microbiology 08/11/11.
Presented by: Andrew Nelson, R.J. Dealy, and Nick Bishop.
Hannover Medical School February 15 th 2010 The gut microbiota shapes intestinal immune response during health and disease Round and Mazmanian, Nature.
VACCINATION. Vaccination: Is The administration of an antigen to stimulate a protective immune response against an infectious agent.
Cancer vaccines are biological response modifiers. They prime the immune system to attack the cancer cells in the body. The goal is to prevent or to treat.
Hannover Medical School January 25 th 2010 Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota Stecher.
Sornkanok Vimolmangkang, Ph.D.
Chapter 17: IR to Infectious Disease In BIOL 304, we examined how pathogens can establish an infection in a susceptible host Re: the 7 components of pathogenicity!!
Active and passive immunization Immunity to infectious microorganisms: Immunity to infectious microorganisms: 1- Active immunization *** natural processes.
Display of the Viral Epitopes on Lactococcus lactis: A Model for Food Grade Vaccine against EV71.
Making Vaccines.
General classes of vaccines An induced mobilization of the immune response for the purpose of therapeutic benefit. Preventative: infectious agents Therapeutic:
Vaccines development of Vibrio vulnificus
Immunoprevention. Definition By using immunological agents to construct, improve or inhibit immune response, people can prevent some diseases.
Adapted from: Project Lead The Way Making Vaccines powerpoint
Edible Vaccines: eating our way to the eradication of disease.
Phagocyte. B cells Receptor B Cell Naïve B cell B cells and antibodies daughter cells produce antibodies phagocyte consumes an antibody coated virus.
The Body’s Defenses Chapter 43.
Plant Immunology.
Edible Vaccines. HOW IS IT DONE Approach 1 DNA sequences encoding antibodies (molecule which is able to recognise a disease-causing agent) are inserted.
Presented By Dr. Md. Mahmudul Hasan M,Phil (Microbiology, P- I) EDIBLE VACCINES : CURRENT STATUS AND FUTURE.
Downloaded from Lecture40&41 Edible Vaccines.
The Immune System. The First Lines of Defense: – Skin – Antimicrobial proteins – Cilia – Gastric Juice – Symbiotic bacteria – your ‘microbiome’
VAKSIN. INTRODUCTION AND HISTORY Vaccination can be defined as a deliberate attempt to induce protection against disease with the goal of inducing active.
___________DEFENSES of the HOST: THE IMMUNE RESPONSE
Infection and Disease Fungi Parasites Nosocomial infection Diagnosis of infectious disease.
14. Immunodiagnosis, Immunotherapy & Vaccination 王 家 鑫, MD College of Veterinary Medicine.
Methods by which pathogens cause disease: Adhesion: bacteria must bind to the cell surfaces Colonization: bacteria produce proteins and colonize parts.
Biotechnology Vaccines Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:
Active immunization Immunology and microbiology 2011.
SYNTHETIC POLY-CTL EPITOPE DNA VACCINE AGAINST HIV-1 Bazhan S.I, Belavin P.A., SereginS.V., Danilyuk N.K., Babkina I.K., Karpenko L.I., Nekrasova N.A.,
Making Vaccines. Effective Vaccines Have low levels of side effects or toxicity. Protect against exposure to natural, or wild forms of the pathogen. Should.
Nature reviews Microbiology January Gram-negative Enterobacteria Diameter µm S. enterica serovar Typhimurium serovar Typhi Daniel Elmer.
CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.
Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses Alexandra Scalvini & Émilien Gimaret Michelle Meyer, Tania Garron,
Date of download: 5/31/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Regression of HPV-Positive Tumors Treated With a.
Viral vaccines  .
DESIGN AND PRODUCTION OF RECOMBINANT SUBUNIT VACCINES BY Dr. Ahmad Usman Zafar National Centre of Excellence in Molecular Biology, Lahore.
HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK
Edible Vaccines.
Ahangarzadeh, Sh. *1 Bandehpour, M.1, Kazemi, B.1 , Yarian, F.1
Cloning and expression in Lactobacillus acidophilus
DISCUSSION AND CONCLUSION
José Antonio Agüero-Fernández1† and José Pérez-Casal2
Communicable Diseases
Vaccination -Several weeks are required before the immune system develops immunity to a new antigen -To overcome this problem, vaccinations safely give.
Edible Vaccines: eating our way to the eradication of disease
Engineering regulatory T cells against factor VIII inhibitors
Gut Microbiota: Mining for Therapeutic Potential
INTERLEUKIN 10 (IL-10) CATEGORY: RECEPTORS & MOLECULES
Week 15 Vocab Definitions
Experimental setup.A, topology models of the overexpressed membrane protein GFP fusions. Experimental setup.A, topology models of the overexpressed membrane.
Modular Three-component Delivery System Facilitates HLA Class I Antigen Presentation and CD8+ T-cell Activation Against Tumors  Benjamin J Umlauf, Chin-Ying.
Brian K. Coombes, Yanet Valdez, B.Brett Finlay  Current Biology 
Third Line of Defense Immune Response (Specific Defense)
Role of Research in Prevention
Introduction/Terminology
Activity-dependent suppression of the proapoptotic gene Puma protects neurons. Activity-dependent suppression of the proapoptotic gene Puma protects neurons.
Signal Transduction & Virulence
VACCINATION. Vaccination: Is The administration of an antigen to stimulate a protective immune response against an infectious agent.
Presentation transcript:

Use of Lactic acid Bacteria as Antigen Delivery Vehicle Kim, Tae-Woon Lab. of Food Biochemistry

Development of mucosal vaccines based on lactic acid bacteria Mucosal surface – the first line of defense Macdonald et al. (2005) Mucosal vaccine is administrated orally and induces mucosal immune responses to prevent infectious diseases

Advantages of a Mucosal Vaccine Conventional vaccineMucosal vaccine Administrated by needle Require professional skill Risk of cross-contamination Defense after the invasion Induce systemic immunity Administrated orally Easy and No stress Defense both at the front of invasion and after the invasion Induce both systemic and mucosal immunity

Types of Mucosal Vaccines Pathogen-based Attenuated pathogen Antigen-capsulated ISCOM (immune stimulating complex) Liposome Chitosan microparticles ADA (antigen delivery agent) - mediated Plant Potato, tomato etc. Commensal bacteria Lactic acid bacteria

Lactic acid Bacteria Generally regarded as safeAdjuvant effects Lactic acid bacteria are promising antigen delivery agents!!! Mucosal vaccine Lactococcus Lactobacillus Bifidobacterium Protective antigen

Membrane Cell Wall Cytoplasm Extracellular P T Target gene SS P T Target gene SS CWA P T Target gene (A) Cytoplasm (B) Supernatant (C) Cell wall anchor - Expression of heterologous protein on lactic acid bacteria -

Listeria monocytogenes Intracellular pathogen Production of listeriolysin O (LLO) encoding hlyA (1.5 kb) LLO Hemolysis - Example of construction of mucosal vaccine -

1500bp 1000bp500bp 5’3’ Hemolysis LLO 2. LLOmut 3. LLOshort Mutation LLO- L. caseiL. casei L. monocytogenes hlyA - Construction of LLO-expressing L. casei - Safe delivery vehicle + Non-toxic antigen Safe delivery vehicle + Non-toxic antigen

Salmonella enterica serovar Enteritidis (SE) Salmonella enterica serovar Enteritidis (SE) Construction of FliC-expressing Lc. lactis Egg-associated salmonellosis SE contamination in/on egg SE-carrier hens SE-carrier hens Vaccination of hens control of SE contamination control of SE contamination

antigen delivery vehicle Generally regarded as safe (GRAS) (GRAS) Lactococcus lactis protective antigen SE Flagellin (FliC) Major immunogen of Salmonella TLR-5 mediated immune responses The mucosal vaccine which confers both systemic and local immunity Construction of FliC-expressing Lc. lactis

Bacterial strain IFN-γ, IL-2, TNF-α IL-4, IL-6, IL-10 Cell-mediated immunity Humoral immunity Lactococcus lactis Th 1 cells Th 2 cells Th 1 Th 2 Lactococcus lactis + FliC Th 0

PSSfliCAnchor EcoRVKpn1 - Construction of Lc.lactis expressing fliC on its surface - fliC : M84974 pALC1 (5.957 Kb) rep ermA P SS Anchor MCS Transformation Selection PCR & Sequencing

- The result of Western blot - kDa G53 H45H61527 M : Marker 1. Whole cell lysates of strains expressing fliC on cell surface 2. Whole cell lysates of strains containing vector only M

- The results of flow cytometry (Lc.lactis expressing fliC on the cell surface) - L.lactis H45 : Th 1, TNF-α(-) L.lactis H61 : Th 2 L.lactis 527 : Neutral L.lactis G53 : Th 1, TNF-α(+)

Lc.lactis exprssing fliC on cell surfaceLc.lactis containing vector only - Bright field images -

- Immunofluorescence images - Lc.lactis exprssing fliC on cell surfaceLc.lactis containing vector only

- Caco-2 cells -

FliC Control FliC Control Invasion into Caco-2 cellsIL-8 secretion in Caco-2 cells

Immunization of mice with Lactococcus lactis expressing fliC Immunization of mice with Lactococcus lactis expressing fliC anti-FliC protection IFN-γ

Conclusion 1. Possibility 2. Problem - Thank you for your attention !!! -